Moody National Bank Trust Division acquired a new position in shares of Mettler-Toledo International Inc. (NYSE:MTD – Get Rating) during the second quarter, HoldingsChannel reports. The institutional investor acquired 349 shares of the medical instruments supplier’s stock, valued at approximately $401,000.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its holdings in Mettler-Toledo International by 0.7% during the first quarter. Vanguard Group Inc. now owns 2,534,104 shares of the medical instruments supplier’s stock worth $3,479,806,000 after purchasing an additional 17,826 shares in the last quarter. BlackRock Inc. raised its holdings in Mettler-Toledo International by 5.0% during the first quarter. BlackRock Inc. now owns 2,127,758 shares of the medical instruments supplier’s stock worth $2,921,815,000 after purchasing an additional 100,381 shares in the last quarter. State Street Corp raised its holdings in Mettler-Toledo International by 2.8% during the fourth quarter. State Street Corp now owns 1,004,301 shares of the medical instruments supplier’s stock worth $1,704,510,000 after purchasing an additional 27,181 shares in the last quarter. Capital International Investors raised its holdings in Mettler-Toledo International by 12.3% during the first quarter. Capital International Investors now owns 591,960 shares of the medical instruments supplier’s stock worth $812,874,000 after purchasing an additional 64,931 shares in the last quarter. Finally, Geode Capital Management LLC raised its holdings in Mettler-Toledo International by 2.2% during the fourth quarter. Geode Capital Management LLC now owns 467,100 shares of the medical instruments supplier’s stock worth $791,240,000 after purchasing an additional 10,276 shares in the last quarter. Institutional investors and hedge funds own 93.00% of the company’s stock.
Analyst Upgrades and Downgrades
A number of analysts have weighed in on the stock. Stifel Nicolaus raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating and set a $1,500.00 price objective on the stock in a report on Tuesday, September 6th. StockNews.com raised shares of Mettler-Toledo International from a “buy” rating to a “strong-buy” rating in a report on Friday. The Goldman Sachs Group cut their target price on shares of Mettler-Toledo International from $1,280.00 to $1,140.00 and set a “sell” rating on the stock in a report on Thursday, July 14th. UBS Group initiated coverage on shares of Mettler-Toledo International in a report on Wednesday, July 20th. They issued a “neutral” rating and a $1,237.00 target price on the stock. Finally, TheStreet cut shares of Mettler-Toledo International from a “b” rating to a “c+” rating in a report on Thursday, July 28th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, two have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Mettler-Toledo International has an average rating of “Moderate Buy” and an average price target of $1,338.60.
Insider Activity at Mettler-Toledo International
Mettler-Toledo International Stock Performance
NYSE:MTD opened at $1,198.50 on Monday. The firm’s fifty day moving average price is $1,269.60 and its 200 day moving average price is $1,275.46. Mettler-Toledo International Inc. has a 1-year low of $1,082.78 and a 1-year high of $1,714.75. The company has a debt-to-equity ratio of 250.82, a current ratio of 1.18 and a quick ratio of 0.77. The firm has a market cap of $26.97 billion, a price-to-earnings ratio of 33.77, a price-to-earnings-growth ratio of 2.95 and a beta of 1.14.
Mettler-Toledo International (NYSE:MTD – Get Rating) last posted its quarterly earnings data on Friday, July 29th. The medical instruments supplier reported $9.39 earnings per share for the quarter, beating analysts’ consensus estimates of $8.78 by $0.61. Mettler-Toledo International had a net margin of 21.23% and a return on equity of 799.34%. The firm had revenue of $978.39 million for the quarter, compared to analyst estimates of $951.81 million. During the same period last year, the firm posted $8.10 EPS. Mettler-Toledo International’s quarterly revenue was up 5.8% on a year-over-year basis. On average, sell-side analysts expect that Mettler-Toledo International Inc. will post 38.99 EPS for the current year.
Mettler-Toledo International Profile
Mettler-Toledo International Inc engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
- Get a free copy of the StockNews.com research report on Mettler-Toledo International (MTD)
- Kroger’s is Your One-Stop Consumer Staples Stock
- Adobe Perfects the Art of the Faceplant for Investors
- Tax Credits are the Incentives in the Inflation Reduction Act
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- 3 Banks Worth Considering For Q4
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.